Jennifer Leslie Harris,Nanxin Li,Timothy R Smith,Yael Mosse,Andrew Wood
申请号：
US16035774
公开号：
US20180318305A1
申请日:
2018.07.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical combination comprising, separately or together, (1) a first agent which is an ALK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof. The invention further relates the use of such combination in the treatment or prevention of proliferative diseases.
